• Skip to primary navigation
  • Skip to main content

Puglisi Consulting for Artificial Intelligence

Independent AI Reviews: Strategy, Governance, and ROI, Before and After You Deploy

  • Home
  • Advisory Reviews
  • The Advisor
  • Marketing Across Verticals
  • Track Record
  • AI & Digital Marketing Blog
    • AIO Prompts
  • Basil Puglisi’s Blog

StemCyte

March 30, 2015 by BasilPuglisi

StemCyte150x150StemCyte™ has extensive experience providing banked cord blood units for transplants in children and adults with life-threatening diseases. Other private cord blood banks may have provided family-related cord blood for transplants, but only StemCyte’s™ cord blood units have been used in over 1900 unrelated donor transplants, the most challenging of transplants.

Even after over 10 years in frozen storage, StemCyte’s™ cord blood units have been proven to engraft rapidly and completely in patients. The majority of these transplanted units were processed using StemCyte’s™ proprietary MaxCell (plasma depletion) method.

We believe that the success of our cord blood transplants results from our StemCyte’s™ experience and attention to quality in processing, freezing, and storing cord blood, as well as our extensive experience with tissue typing (HLA) techniques.

To date, more than 80 diseases have been successfully treated with stem cells. These include cancers (leukemias, lymphomas, multiple myeloma), blood disorders (thalassemias, sickle cell anemia, Fanconi anemia), and immune deficiency diseases.

Click here to view diseases treated with StemCyte™ cord blood units.

 

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Like this:

Like Loading…

Filed Under: Bronze Sponsor

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

© 2005 to 2026 Puglisi Consulting | basil@puglisiconsulting.com | basilpuglisi.com

Loading Comments...
%d